Offstream
news

---

Changes

1. Greece suspends planned rollout of the Johnson & Johnson vaccine pending review from the European Medicines Agency.
   2021-04-20 00:26:43 (First version)
2. Greece suspends its planned rollout of the Johnson & Johnson vaccine pending a review from the European Medicines Agency.
   (Current version)

---

Related

The EMA and the ECDC approves the mixing and matching of two different COVID-19 vaccines for both initial and booster doses.
2021-12-7

Kuwait approves the usage of the single-dose Johnson & Johnson COVID-19 vaccine, becoming the fourth vaccine to be approved in the country.
2021-06-8

Italy opens vaccinations for anyone over the age of 12 after the European Medicines Agency approved the Pfizer-BioNTech vaccine for people between the ages of 12 and 15.
2021-06-3

The Medicines and Healthcare products Regulatory Agency approves the use of the single-dose Johnson & Johnson COVID-19 vaccine, becoming the fourth vaccine to be approved in the United Kingdom.
2021-05-28

Belgium suspends the use of the Johnson & Johnson COVID-19 vaccine for people under the age of 41 following the death of a woman who had received the vaccine last week and who was showing "serious thrombosis and reduced blood platelets".
2021-05-26

South Africa resumes its use of the Johnson & Johnson vaccine to healthcare workers after a pause of more than two weeks, following the drug authority decision that the vaccine is safe.
2021-04-28

Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.
2021-04-7

Brazil's health regulator Anvisa approves the emergency use of the single-dose Johnson & Johnson vaccine.
2021-03-31

U.S. President Joe Biden announces that Merck & Co. will produce single-shot Johnson & Johnson vaccine to help his administration goal for vaccinating every adult by the end of May.
2021-03-2

The Russian Direct Investment Fund files the registration of the Sputnik V vaccine with the European Medicines Agency with the first review expected in February.
2021-01-20